Company Filing History:
Years Active: 1997
Title: David J McClain: Innovator in Hantavirus Vaccine Development
Introduction
David J McClain is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of vaccine development, particularly in relation to Hantaviruses. His work has the potential to impact public health by providing protective immune responses against these viruses.
Latest Patents
David J McClain holds 1 patent for a Hantavirus vaccine. This patent discloses vaccine formulations designed to induce a protective immune response to Hantaviruses in humans. The formulations include an attenuated vaccinia virus vector containing cDNAs encoding the Hantavirus nucleocapsid N protein, as well as G1 and G2 glycoproteins. The patent also outlines methods for utilizing these formulations effectively.
Career Highlights
David J McClain is associated with the US Government as represented by the Secretary of the Army. His work in vaccine research and development has been instrumental in advancing the understanding and prevention of Hantavirus infections. His dedication to public health and safety is evident through his innovative contributions.
Collaborations
Some of his notable coworkers include Connie S Schmaljohn and Joel Dalrymple, who is deceased. Their collaborative efforts have likely contributed to the advancements in vaccine research and development.
Conclusion
David J McClain's work in developing a Hantavirus vaccine showcases his commitment to innovation in public health. His contributions are vital in the ongoing fight against viral infections, and his patent represents a significant step forward in vaccine technology.